Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFα-induced apoptosis

Clinical Cancer Research

Volumn 17, Issue 24, 2011, Pages 7551-7562

  Lee, Jin Hee ^a   Kang, Min Ju ^a   Han, Hye Yeon ^a   Lee, Min Goo ^a   Jeong, Seong In ^a   Ryu, Byung Kyu ^a   Ha, Tae Kyu ^a   Her, Nam Goo ^a   Han, Jikhyon ^a   Park, Sun Jin ^b   Lee, Kil Yeon ^b   Kim, Hyo Jong ^b   Chi, Sung Gil ^a  

^a Korea University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; PROTEIN PRKCDBP; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER STAGING; CELL CYCLE G1 PHASE; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CACO-2 CELLS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; NF-KAPPA B; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84055222098     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-1026     Document Type: Article

References (41)

1. Xu XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, et al. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res 2001;61:7943-9. (Pubitemid 33049385)
2. Zöchbauer-Muller S, Fong KM, Geradts J, Xu X, Seidl S, End-Pfutzenreuter A, et al. Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene 2005;24:6249-55. (Pubitemid 43080048)
3. Lee JH, Byun DS, Lee MG, Ryu BK, Kang MJ, Chae KS, et al. Frequent epigenetic inactivation ofhSRBCin gastric cancer and its implication in attenuated p53 response to stresses. Int J Cancer 2008;122:1573-84.
4. Mineo C, Ying YS, Chapline C, Jaken S, Anderson RG. Targeting of protein kinase Cα to caveolae. J Cell Biol 1998;141:601-10.
5. Izumi Y, Hirai S, Tamai Y, Fujise-Matsuoka A, Nishimura Y, Ohno S. A protein kinase Cδ-binding protein SRBC whose expression is induced by serum starvation. J Biol Chem 1997;272:7381-9. (Pubitemid 27166449)
6. Gustincich S, Schneider C. Serum deprivation response gene is induced by serum starvation but not by contact inhibition. Cell Growth Differ 1993;4:753-60.
7. Jansa P, Mason SW, Hoffmann-Rohrer U, Grummt I. Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. EMBO J 1998;17:2855-64. (Pubitemid 28227132)
8. Chapline C, Cottom J, Tobin H, Hulmes J, Crabb J, Jaken S. A major, transformation-sensitive PKC-binding protein is also a PKC substrate involved in cytoskeletal remodeling. J Biol Chem 1998;273:19482-9. (Pubitemid 28366998)
9. Jaken S, Parker PJ. Protein kinase C binding partners. Bioessays 2000;22:245-54. (Pubitemid 30144417)
10. Parton RG, Simons K. The multiple faces of caveolae. Nature Rev Mol Cell Biol 2007;8:185-94.
11. de Laurentiis A, Donovan L, Arcaro A. Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem J 2007;1:12-32.
12. McMahon KA, Zajicek H, Li WP, Peyton MJ, Minna JD, Hernandez VJ, et al. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J 2009;28:1001-15.
13. Liu L, Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem 2008;283:4314-22.
14. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008;132:113-24.
15. Hansen CG, Nichols BJ. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol 2010;20:177-86.
16. Hansen CG, Bright NA, Howard G, Nichols BJ. SDPR induces membrane curvature and functions in the formation of caveolae. Nat Cell Biol 2009;11:807-14.
17. Briand N, Dugail I, Le Lay S. Cavin proteins: new players in the caveolae field. Biochimie 2011;93:71-7.
18. Bastiani M, Liu L, Hill MM, Jedrychowski MP, Nixon SJ, Lo HP, et al. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J Cell Biol 2009;185:1259-73.
19. Roy D, Calaf G, Hei TK. Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation of human breast epithelial cells. Int J Cancer 2003;103:730-7. (Pubitemid 36110228)
20. Zhao B, Bepler G. Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer. Oncogene 2001;20:8154-64. (Pubitemid 34028341)
21. Tran YK, Newsham IF. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. Cancer Res 1996;56:2916-21. (Pubitemid 26199731)
22. Moskaluk CA, Rumpel CA. Allelic deletion in 11p15 is a common occurrence in esophageal and gastric adenocarcinoma. Cancer 1998;83:232-9. (Pubitemid 28317801)
23. Rodriguez E, Rao PH, Ladanyi M, Altorki N, Albino AP, Kelsen DP, et al. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res 1990;50:6410-6. (Pubitemid 20323707)
24. Tong SY, Ki KD, Lee JM, Kang MJ, Ha TK, Chung SI, et al. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation. Acta Obstet Gynecol Scand 2010;89: 629-35.
25. Gschwendt M. Protein kinase Cδ. Eur J Biochem 1999;259:555-64.
26. Chung SK, Lee MG, Ryu BK, Lee JH, Han J, Byun DS, et al. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses. Gastroenterology 2007;132: 2459-77. (Pubitemid 46890872)
27. Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, et al. NF-κBactivates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Gastroenterology 2008;135: 2030-42.
28. Hiltunen MO, Koistinaho J, Alhonen L, Myöhänen S, Marin S, Kosma VM, et al. Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer. Br J Cancer 1997;76:1124-30. (Pubitemid 27448006)
29. Vincent A, Perrais M, Desseyn JL, Aubert JP, Pigny P, Van Seuningen I. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. Oncogene 2007;26:6566-76. (Pubitemid 47530602)
30. Zhou BP, Liao Y, Xia W, Zou Y, Spohn B, Hung MC. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001;3:973-82. (Pubitemid 34428742)
31. Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K, et al. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem 2002;277:21843-50. (Pubitemid 34952337)
32. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009;9:361-71.
33. Talmadge JE, Phillips H, Schneider M, Rowe T, Pennington R, Bowersox O, et al. Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res 1988;48:544-50. (Pubitemid 18056519)
34. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 1987;329:630-2. (Pubitemid 17140112)
35. Orosz P, Echtenacher B, Falk W, Rüschoff J, Weber D, Männel DN. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med 1993;177:1391-8. (Pubitemid 23117129)
36. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009;457:102-6.
37. Kraus S, Arber N. Inflammation and colorectal cancer. Curr Opin Pharmacol 2009;9:405-10.
38. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, et al. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-70. (Pubitemid 351206546)
39. Matthews CP, Colburn NH, Young MR. AP-1 a target for cancer prevention. Curr Cancer Drug Targets 2007;7:317-24. (Pubitemid 46849236)
40. Wang P, Qiu W, Dudgeon C, Liu H, Huang C, Zambetti GP, et al. PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis. Cell Death Differ 2009;16:1192-202.
41. Liu Z, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996;87:565-76. (Pubitemid 26374329)